Gene · 887
Papers2,046
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,046
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune gastritis diverges from a shared corpus origin: molecular reconstruction of the adenocarcinoma axis and clinical anchoring of the neuroendocrine axis. | Front Immunol | 2026 | 42712509 | PubTator, text mining | PubMed |
| Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications. | Theranostics | 2026 | 42707991 | PubTator, text mining | PubMed |
| Targeted radionuclide-drug conjugates: Current status and perspectives. | Eur J Med Chem | 2026 | 42520735 | PubTator, text mining | PubMed |
| Therapeutic potential of pachymic acid in glioma: a comprehensive approach combining experimental validation, network pharmacology, and machine learning. | Brain Res | 2026 | 42468874 | PubTator, text mining | PubMed |
| Immune and clinicopathological features of molecularly defined prolactinoma subtypes. | J Neurosurg | 2026 | 42361377 | PubTator, text mining | PubMed |
| Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111In/177Lu Theranostics. | Bioconjug Chem | 2026 | 42283376 | PubTator, text mining | PubMed |
| Effects of Lacticaseibacillus paracasei HP7 Against Helicobacter pylori-Induced Gastric Mucosal Inflammation and Mucosal Protection. | J Med Food | 2026 | 41870161 | PubTator, text mining | PubMed |
| A progressive fine-tuning framework with dynamic parameter selection for low-resource peptide-GPCR interaction prediction. | Brief Bioinform | 2026 | 41838876 | PubTator, text mining | PubMed |
| Integrated network toxicology and computational profiling of acetyl tributyl citrate-related mechanisms in Alzheimer's disease. | J Alzheimers Dis | 2026 | 41823681 | PubTator, text mining | PubMed |
| Gastrin ameliorates heart failure and suppresses myocardial remodeling via the JAK2/STAT3 and ERK1/2 pathways. | PLoS One | 2026 | 41785239 | PubTator, text mining | PubMed |
| Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2026 | 41751398 | PubTator, text mining | PubMed |
| Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins. | Toxins (Basel) | 2026 | 41745735 | PubTator, text mining | PubMed |
| Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions. | Eur J Nucl Med Mol Imaging | 2026 | 41689648 | PubTator, text mining | PubMed |
| Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. | Pharmaceutics | 2026 | 41599245 | PubTator, text mining | PubMed |
| Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth. | Cell Commun Signal | 2026 | 41546097 | PubTator, text mining | PubMed |
| Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting. | RSC Adv | 2026 | 41509636 | PubTator, text mining | PubMed |
| Elucidating pathway-selective biased CCKBR agonism for Alzheimer's disease treatment. | Cell | 2026 | 41270732 | PubTator, text mining | PubMed |
| Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosis. | J Bone Miner Res | 2026 | 41206736 | PubTator, text mining | PubMed |
| Gastrin-dependent expansion of Cck2r+ corpus progenitors accelerates ulcer healing and inhibits gastric dysplasia. | Gut | 2026 | 40983503 | PubTator, text mining | PubMed |
| Fundamental role of brain-organ interaction in behavior-driven holistic homeostasis. | Fundam Res | 2025 | 41467014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/887/papers